As previously announced, Active Biotech AB’s (Active Biotech) Annual General Meeting approved the proposed rights issue (1:4), whereby shareholders are entitled to one (1) new share for every four (4) shares held. The subscription price is set at SEK 20. The record date is May 20, 2009. NASDAQ OMX Derivatives Markets has carried out a re-calculation of options and forwards in Active Biotech. For further information, please see the attached file.
Attachments
